Skip to main navigation Skip to search Skip to main content

Origin of ganglioside complex antibodies in Guillain-Barré syndrome

  • Mark L. Kuijf
  • , Peggy C. R. Godschalk
  • , Michel Gilbert
  • , Hubert P. Endtz
  • , Anne P. Tio-Gillen
  • , C. Wim Ang
  • , Pieter A. van Doorn
  • , Bart C. Jacobs

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The origin of antibodies to ganglioside complexes, as new immunotargets for Guillain-Barré syndrome (GBS), is unknown. This was investigated in 21 GBS patients from which Campylobacter jejuni was isolated. Two of these patients had serum IgG to the GM1/GD1a complex and two other patients had IgG to the GQ1b/GD1a complex. These pairs of patients were clinically distinct. These antibodies all cross-reacted to lipo-oligosaccharides (LOS) from the autologous C. jejuni strain. Previous mass spectrometry studies on these LOS showed the presence of oligosaccharides with a similar structure, further supporting the hypothesis that in these patients LOS induced the ganglioside complex antibodies
Original languageEnglish
Pages (from-to)69-73
JournalJournal of neuroimmunology
Volume188
Issue number1-2
DOIs
Publication statusPublished - 2007

Fingerprint

Dive into the research topics of 'Origin of ganglioside complex antibodies in Guillain-Barré syndrome'. Together they form a unique fingerprint.

Cite this